0,952  0,002  Antihypercholesterolemic
0,939  0,003  TNF expression inhibitor
0,932  0,002  Cholesterol antagonist
0,930  0,003  Carcinogenic
0,900  0,001  UGT2B1 substrate
0,883  0,001  Antihyperlipoproteinemic
0,864  0,003  NOS3 expression inhibitor
0,863  0,006  CYP3A4 substrate
0,857  0,006  Teratogen
0,849  0,004  Chemopreventive
0,838  0,002  UGT1A4 substrate
0,843  0,010  Antiinflammatory
0,833  0,007  Embryotoxic
0,804  0,005  Bone diseases treatment
0,802  0,005  Respiratory analeptic
0,786  0,004  Hepatic disorders treatment
0,796  0,017  Apoptosis agonist
0,767  0,005  Antiosteoporotic
0,764  0,003  Sulfotransferase substrate
0,754  0,002  Pregnane X receptor agonist
0,753  0,005  CYP2C19 substrate
0,748  0,001  Cholesterol synthesis inhibitor
0,750  0,007  Chemoprotective
0,744  0,005  Proliferative diseases treatment
0,734  0,003  Anesthetic general
0,730  0,003  Hair growth stimulant
0,731  0,005  Lipoprotein disorders treatment
0,716  0,006  CTGF expression inhibitor
0,703  0,003  Antipruritic, allergic
0,693  0,002  UGT2B4 substrate
0,710  0,019  Transcription factor NF kappa B inhibitor
0,690  0,009  Sensitization
0,676  0,002  Anticataract
0,670  0,005  UGT1A1 substrate
0,666  0,004  Prostatic (benign) hyperplasia treatment
0,659  0,008  NOS2 expression inhibitor
0,653  0,010  Analeptic
0,647  0,004  Anesthetic
0,639  0,002  UGT2B7 substrate
0,633  0,004  UGT1A3 substrate
0,635  0,009  Cytotoxic
0,630  0,006  UDP-glucuronosyltransferase substrate
0,627  0,008  UGT1A6 substrate
0,614  0,003  Retinoprotector
0,619  0,019  CYP2C9 substrate
0,604  0,003  Androgen antagonist
0,604  0,010  Antipsoriatic
0,624  0,033  Caspase 9 stimulant
0,593  0,016  Atherosclerosis treatment
0,591  0,014  Immunosuppressant
0,602  0,034  Antineoplastic (breast cancer)
0,571  0,008  Hypolipemic
0,565  0,003  Interferon gamma antagonist
0,558  0,002  Sodium/bile acid cotransporter inhibitor
0,565  0,013  Apoptosis antagonist
0,551  0,005  Diuretic
0,548  0,007  Amyotrophic lateral sclerosis treatment
0,542  0,003  Abortion inducer
0,533  0,003  Prostate disorders treatment
0,528  0,001  5-Alpha-reductase inhibitor
0,542  0,016  AR expression inhibitor
0,532  0,006  Hepatoprotectant
0,529  0,003  Autism spectrum disorders treatment
0,529  0,003  Lipocortins synthesis antagonist
0,547  0,024  Prostate cancer treatment
0,525  0,003  UGT2B9 substrate
0,555  0,036  Cyclophilin D inhibitor
0,555  0,036  Antidiabetic
0,540  0,024  Immunostimulant
0,530  0,017  Antifungal
0,514  0,002  Antipruritic, non-allergic
0,529  0,018  Antineoplastic (pancreatic cancer)
0,540  0,031  Antibacterial
0,510  0,005  Antiacne
0,520  0,021  Inflammatory Bowel disease treatment
0,518  0,022  Antineoplastic (melanoma)
0,489  0,001  5-Alpha-reductase 2 inhibitor
0,490  0,004  Antiinfertility, female
0,490  0,006  Contraceptive
0,525  0,041  Antineoplastic (lung cancer)
0,479  0,001  5-Alpha-reductase 1 inhibitor
0,496  0,018  Metabolic disease treatment
0,476  0,012  Antineoplastic (liver cancer)
0,481  0,017  Nitric oxide antagonist
0,471  0,012  Interleukin 2 agonist
0,457  0,005  Liver fibrosis treatment
0,467  0,015  Renal disease treatment
0,448  0,005  DNA polymerase I inhibitor
0,463  0,032  Antineoplastic (ovarian cancer)
0,433  0,005  Growth factor agonist
0,428  0,008  Amylase inhibitor
0,450  0,031  Immunomodulator
0,420  0,005  Liver cirrhosis treatment
0,416  0,003  Choleretic
0,403  0,010  Phospholipase C inhibitor
0,444  0,051  Antileukemic
0,398  0,007  Antiviral (Influenza A)
0,393  0,004  Farnesoid X receptor antagonist
0,403  0,019  Sedative
0,376  0,002  Liver X receptor alpha agonist
0,406  0,034  Antioxidant
0,375  0,003  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,380  0,009  Protein kinase stimulant
0,407  0,038  Antihypertensive
0,388  0,022  Antineoplastic (endocrine cancer)
0,383  0,017  Antiparkinsonian, rigidity relieving
0,377  0,014  Antiviral (Influenza)
0,364  0,003  Androgen agonist
0,387  0,027  Antineoplastic (renal cancer)
0,398  0,038  Antiepileptic
0,393  0,037  Antineoplastic (glioma)
0,356  0,005  Contraceptive female
0,372  0,027  Angiogenesis stimulant
0,369  0,024  Interleukin agonist
0,381  0,044  Antineoplastic (brain cancer)
0,369  0,042  UGT1A9 substrate
0,378  0,051  Caspase 3 stimulant
0,338  0,013  UGT2B15 substrate
0,339  0,017  Melanin inhibitor
0,341  0,024  Muscle relaxant
0,320  0,005  LDLR expression enhancer
0,319  0,004  UGT2B10 substrate
0,310  0,002  Anticholelithogenic
0,309  0,005  Hedgehog signaling inhibitor
0,309  0,009  Antifungal enhancer
0,300  0,002  Arachidonic acid antagonist
0,301  0,004  Actinic keratosis treatment
0,309  0,013  Antidiarrheal
0,297  0,003  Bile acid receptor antagonist
0,354  0,060  ICAM1 expression inhibitor
0,356  0,063  Antineoplastic (colorectal cancer)
0,303  0,017  Bone formation stimulant
0,290  0,004  CDC25A inhibitor
0,303  0,017  Neurotrophic factor enhancer
0,290  0,007  Alcohol dehydrogenase substrate
0,324  0,041  Antineoplastic (glioblastoma multiforme)
0,344  0,062  Antineoplastic (colon cancer)
0,281  0,003  Glycine receptor agonist
0,327  0,050  Antineoplastic (cervical cancer)
0,319  0,046  Antineoplastic (lymphoma)
0,276  0,005  Aromatase inhibitor
0,281  0,012  Psychosexual dysfunction treatment
0,374  0,111  Alzheimer's disease treatment
0,286  0,025  Antiviral (Herpes)
0,295  0,035  Platelet adhesion inhibitor
0,300  0,042  Antineoplastic (sarcoma)
0,285  0,028  Male reproductive disfunction treatment
0,312  0,058  Antineoplastic (multiple myeloma)
0,302  0,051  Cardiodepressant
0,289  0,038  Wound healing agent
0,256  0,005  ABCA1 expression enhancer
0,306  0,065  Radioprotector
0,252  0,012  Neurotrophic factor
0,288  0,057  Hypoglycemic
0,261  0,034  Diabetic retinopathy treatment
0,304  0,080  CYP2D6 substrate
0,270  0,049  Mutagenic
0,220  0,003  UGT2B11 substrate
0,268  0,053  Antiulcerative
0,274  0,063  Antidiabetic symptomatic
0,251  0,041  P-glycoprotein inhibitor
0,242  0,032  Diabetic nephropathy treatment
0,239  0,029  NOS3 expression enhancer
0,238  0,029  Antipruritic
0,210  0,004  Hypercalcemia treatment
0,209  0,003  RNA-directed RNA polymerase stimulant
0,231  0,026  Toxic, respiratory center
0,206  0,004  Anabolic
0,204  0,004  Hyperparathyroidism treatment
0,296  0,096  Calcium channel activator
0,308  0,111  Antiobesity
0,209  0,019  Antihemorrhagic
0,258  0,070  Myocardial infarction treatment
0,189  0,002  Cholesterol absorption inhibitor
0,245  0,058  Antiviral (HIV)
0,265  0,081  Antidiabetic (type 2)
0,193  0,008  Estrogen agonist
0,187  0,006  Paget's disease treatment
0,200  0,020  Endometrios treatment
0,186  0,009  Postmenopausal disorders treatment
0,179  0,004  Liver X receptor agonist
0,191  0,019  Growth stimulant
0,182  0,012  Contraceptive male
0,191  0,022  Microtubule formation inhibitor
0,208  0,040  Muscular dystrophy treatment
0,185  0,017  Antineoplastic, alkylator
0,189  0,023  Antineoplastic antibiotic
0,167  0,007  Lanosterol 14 alpha demethylase inhibitor
0,164  0,004  Na+ K+ transporting ATPase inhibitor
0,162  0,005  CDC25B inhibitor
0,194  0,039  Skin whitener
0,157  0,003  Vitamin D receptor antagonist
0,166  0,011  SULT1E1 substrate
0,159  0,006  Glycine receptor antagonist
0,230  0,078  Free radical scavenger
0,234  0,085  Antipyretic
0,174  0,025  SULT1A1 substrate
0,146  0,003  Farnesoid X receptor agonist
0,216  0,079  RNA-directed DNA polymerase inhibitor
0,157  0,021  Estrogen antagonist
0,212  0,076  Antihypertriglyceridemic
0,218  0,084  Antihypotensive
0,245  0,112  Antimycobacterial
0,183  0,051  Acute respiratory distress syndrome (ARDS) treatment
0,132  0,001  Hedgehog signaling activator
0,167  0,039  Protein-tyrosine phosphatase 1B inhibitor
0,206  0,082  VCAM1 expression inhibitor
0,122  0,004  Liver X receptor beta agonist
0,209  0,092  Cytostatic
0,188  0,074  Antihelmintic
0,140  0,031  Antineoplastic alkaloid
0,113  0,004  Lipocortins synthesis agonist
0,126  0,017  Estrogen receptor alpha antagonist
0,112  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,128  0,022  Inducible nitric-oxide synthase inhibitor
0,109  0,006  Heme oxygenase stimulant
0,159  0,058  Skeletal muscle relaxant
0,203  0,104  Antineoplastic (non-small cell lung cancer)
0,100  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,112  0,017  SULT1A2 substrate
0,120  0,025  Transcription factor NF kappa B stimulant
0,122  0,030  Estrogen receptor beta antagonist
0,201  0,109  Vascular (periferal) disease treatment
0,095  0,004  Parathyroid hormone antagonist
0,127  0,037  Toll-Like receptor 4 antagonist
0,159  0,070  Protein-tyrosine phosphatase inhibitor
0,093  0,008  Postcoital contraceptive
0,090  0,005  Glucocorticoid antagonist
0,185  0,101  Antialcoholic
0,140  0,057  Cyclooxygenase 3 inhibitor
0,216  0,134  Hypoxia-inducible factor 1 alpha inhibitor
0,094  0,012  Estrogen receptor beta agonist
0,127  0,046  Expectorant
0,111  0,030  Antibiotic
0,089  0,010  Progesterone antagonist
0,134  0,057  Antiviral (Hepatitis B)
0,147  0,070  Lipid peroxidase inhibitor
0,080  0,004  Glucose-6-phosphate dehydrogenase inhibitor
0,077  0,002  Vitamin D receptor agonist
0,086  0,011  Estrogen receptor alpha agonist
0,089  0,015  SULT2A1 substrate
0,152  0,078  Eye irritation, high
0,191  0,117  Tumour necrosis factor alpha release inhibitor
0,097  0,025  Cushing's syndrome treatment
0,097  0,025  Premenstrual syndrome treatment
0,162  0,092  Antineoplastic (bone cancer)
0,119  0,049  AMP-activated protein kinase stimulant
0,080  0,011  Aldosterone antagonist
0,070  0,003  Ileal bile acid transport inhibitor
0,124  0,057  Skin irritative effect
0,071  0,004  HMG CoA reductase inhibitor
0,107  0,046  Posttraumatic stress disorder treatment
0,074  0,013  Mineralocorticoid receptor antagonist
0,196  0,135  Cardioprotectant
0,116  0,059  Mucolytic
0,168  0,112  Antiparasitic
0,132  0,077  Antieczematic
0,078  0,024  Nitric oxide donor
0,127  0,075  Interleukin 4 antagonist
0,186  0,134  5 Hydroxytryptamine release stimulant
0,141  0,089  Thrombolytic
0,056  0,005  CYP24 inhibitor
0,115  0,065  Monophenol monooxygenase inhibitor
0,170  0,121  Antineoplastic enhancer
0,140  0,092  Neuropathy treatment
0,157  0,110  Psychostimulant
0,115  0,069  Proteasome inhibitor
0,077  0,032  HIV-1 integrase (Strand Transfer) inhibitor
0,134  0,089  Antifungal (Cryptococcus)
0,133  0,090  Antidiabetic (type 1)
0,116  0,073  Carcinogenic, group 3
0,167  0,125  Antiprotozoal (Leishmania)
0,043  0,004  Corticosteroid-like
0,115  0,077  Aldehyde dehydrogenase inhibitor
0,158  0,121  EphB2 antagonist
0,138  0,102  Uterine stimulant
0,041  0,005  Glucocorticoid agonist
0,051  0,016  Hypogonadism treatment
0,110  0,076  Menstruation disorders treatment
0,139  0,107  Interleukin 6 antagonist
0,035  0,004  Apical sodium codependent bile acid transporter inhibitor
0,172  0,143  DNA damaging
0,060  0,030  Acetyl-CoA transferase inhibitor
0,172  0,143  Spasmolytic
0,077  0,049  Antitreponemal
0,127  0,098  Genotoxic
0,193  0,165  CYP1A2 substrate
0,069  0,042  Andropause treatment
0,052  0,026  Microtubule stabilization
0,083  0,058  Estrogen-related receptor beta agonist
0,031  0,007  Progesterone agonist
0,033  0,009  1,3-Beta-glucan synthase inhibitor
0,094  0,071  Protease inhibitor
0,039  0,016  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,127  0,108  Adenylate cyclase stimulant
0,054  0,036  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,021  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,151  0,134  CYP2B6 inhibitor
0,057  0,043  Botulinum neurotoxin type A inhibitor
0,093  0,080  HDL-cholesterol increasing
0,014  0,002  Transcortin receptor antagonist
0,128  0,117  Aldose reductase substrate
0,079  0,069  T cell inhibitor
0,024  0,014  Estrone sulfatase inhibitor
0,019  0,009  Telomerase stimulant
0,157  0,151  Cardiovascular analeptic
0,098  0,091  Alkylator
0,007  0,002  Vitamin D-like
0,041  0,039  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,046  0,045  Protein 50S ribosomal subunit inhibitor

